Abilify and Calciphylaxis - a phase IV clinical study of FDA data
Summary:
We study 103,481 people who take Abilify (aripiprazole) or have Calciphylaxis. No report of Calciphylaxis is found in people who take Abilify.
The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.
What is Abilify?
Abilify has active ingredients of aripiprazole. It is often used in depression. eHealthMe is studying from 101,450 Abilify users. Check the latest studies of Abilify.
What is Calciphylaxis?
Calciphylaxis (is a syndrome with vascular calcium accumulation) is found to be associated with 129 drugs and 382 conditions by eHealthMe. Check the latest studies of Calciphylaxis.
No report is found.
Do you take Abilify and have Calciphylaxis?
- Check whether Calciphylaxis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Abilify:
- Abilify (101,450 reports)
Calciphylaxis treatments and more:
- Calciphylaxis (2,031 reports)
How severe was Calciphylaxis and when was it recovered:
Expand to all the drugs that have ingredients of aripiprazole:
Browse all side effects of Abilify:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Calciphylaxis:
Browse all the conditions that are associated with Calciphylaxis:
How the study uses the data?
The study uses data from the FDA. It is based on aripiprazole (the active ingredients of Abilify) and Abilify (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- High Blood Pressure and Nephritis - now
- Foreign Body Sensation In Eyes and drugs of ingredients of fish oil - 3 seconds ago
- Could Zyrtec cause Eyelid Oedema? - 13 seconds ago
- Crohn'S Disease and Large Intestine Perforation - 17 seconds ago
- Could Pulmozyme cause Respiratory Tract Infection Bacterial? - 19 seconds ago
- Benicar and Urticaria for Women aged 60+ - 27 seconds ago
- Drug interactions of Dilaudid and Mycelex - 33 seconds ago
- Quinapril and Seroquel drug interactions for men aged 60+ - 35 seconds ago
- Could Permethrin cause Constipation? - 52 seconds ago
- Ibuprofen and Milk Intolerance for Men aged 50-59 - 54 seconds ago